A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
- Status
- RECRUITING
- Phase
- PHASE2
Study of AUBE00 in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Status
- RECRUITING
- Phase
- PHASE3
AK129 Combination Therapy for Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
- Status
- RECRUITING
- Phase
- PHASE1
SCRT + mFOLFOX6 + PD-1 Antibody + Targeted Therapy for HIgh-Risk pMMR/MSS Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
- Status
- RECRUITING
- Phase
- PHASE1
Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1